Drug application
PHOSPHOTOPE (SODIUM PHOSPHATE P-32)
Drugs@FDA NDA 010927 · BRACCO
Key facts
| Drug name | PHOSPHOTOPE |
|---|---|
| Active ingredients | SODIUM PHOSPHATE P-32 |
| Application type | NDA |
| Application number | 010927 |
| Company | BRACCO |
| Dosage forms | SOLUTION, INJECTION, ORAL |
| Strength | 1-8mCi/VIAL |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 5 - New Formulation or New Manufacturer |
| Latest submission status date | May 2, 1957 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.